These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 25989844)

  • 1. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men.
    Estévez-Lamorte N; Foster S; Eich-Höchli D; Moggi F; Gmel G; Mohler-Kuo M
    Eur Arch Psychiatry Clin Neurosci; 2019 Sep; 269(6):667-679. PubMed ID: 30483874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.
    Moggi F; Schorno D; Soravia LM; Mohler-Kuo M; Estévez-Lamorte N; Studer J; Gmel G
    Eur Addict Res; 2020; 26(4-5):233-244. PubMed ID: 32564034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
    van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
    Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men.
    Vogel T; Dom G; van de Glind G; Studer J; Gmel G; Strik W; Moggi F
    Addiction; 2016 Oct; 111(10):1867-78. PubMed ID: 27061514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
    BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and associated factors for adult attention deficit hyperactivity disorder in young Swiss men.
    Estévez N; Eich-Höchli D; Dey M; Gmel G; Studer J; Mohler-Kuo M
    PLoS One; 2014; 9(2):e89298. PubMed ID: 24586672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-Deficit/Hyperactivity Disorder and Alcohol and Other Substance Use Disorders in Young Adulthood: Findings from a Canadian Nationally Representative Survey.
    Fuller-Thomson E; Lewis DA; Agbeyaka S
    Alcohol Alcohol; 2022 May; 57(3):385-395. PubMed ID: 34343246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder and substance abuse: An investigation in young Austrian males.
    Riegler A; Völkl-Kernstock S; Lesch O; Walter H; Skala K
    J Affect Disord; 2017 Aug; 217():60-65. PubMed ID: 28391109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood.
    Ilbegi S; Groenman AP; Schellekens A; Hartman CA; Hoekstra PJ; Franke B; Faraone SV; Rommelse NNJ; Buitelaar JK
    J Neurodev Disord; 2018 Dec; 10(1):42. PubMed ID: 30587104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
    BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
    Yule AM; Martelon M; Faraone SV; Carrellas N; Wilens TE; Biederman J
    J Psychiatr Res; 2017 Feb; 85():49-55. PubMed ID: 27835739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
    Coetzee C; Schellekens AFA; Truter I; Meyer A
    Eur Addict Res; 2023; 29(1):9-18. PubMed ID: 36349763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.